Register  |  Login
Niufan GU Dr. Niufan Gu was born in Shanghai in 1937. He is currently chief psychiatrist at Shanghai Mental Health Center (SMHC), Professor in psychiatry and a doctoral candidate tutor at Shanghai Medical College Fudan University. Upon graduating from Shanghai First Medical College in 1959 he worked at SMHC focusing on clinical practice, education and research. He was previously Vice-President and President of SMHC, Dean of the Shanghai Institute of Mental Health, Director of the WHO Collaborating Centre in Mental Health and was in charge of the national CME program dealing with Clinical Psychopharmacology. He wrote and co-compiled the “Textbook for Further Psychiatry Education”, “Chinese Pharmacopeia”, “Clinical Guide to Chinese Pharmacopoeia”, “Practice of Internal Medicine”, “Psychiatry” as well as other important monographs. His main areas of research include clinical psychopharmacology, molecular genetics of psychiatry and psychiatric hospital management. In 1982, he created and initiated domestic drug clinical studies which were conducted monitoring psychiatric adverse drug reaction (ADR), examining the antipsychotic clozapine and its metabolites serum concentration, and establishing a common method for fast detection of psychotropic drugs in acute poisoning. Under Professor Gu’s leadership, SMHC was approved in 1998 as one of the first "State Based Clinical Drug Trial" sites. To date the team has presided over more than 100 clinical drug trials, including heading up 35 local projects and 10 international projects. On the basis of these trials, Professor Gu and his team were awarded the National Major Project for IND in psychiatry which was the only one in clinical technical platforms for the evaluation of new drugs in Psychiatry (State Funded CNY 10.82 million). Professor Gu has also studied changes of brain CT in schizophrenia patients with high patient family incidence, amyloid beta-protein gene expression in patients with Alzheimer's disease, the structure and function of genes related to mental disorders and done pharmacogenomics and proteomics research. He has participated as a principal investigator on a number of major projects with National Natural Science Foundation, the State Education Commission, the Ministry of Health, the Shanghai Science and Technology Commission, Shanghai Natural Science Foundation and the Ministry of Science and Technology’s 863 project and 973 project. He has published more than 220 papers collected by SCI 35, and produced 10 academic monographs. Prof. Gu was award 1st Prize (1996) and 2nd Prize Science and Technology Advancement Award by the Ministry of Health and 3rd Prize (1993 and 2001) Shanghai Science and Technology Progress Award.